SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6 POS - Post-effective amendments for immediately effective filing:
SEC Accession No. 0001193805-24-000454
Filing Date
2024-03-27
Accepted
2024-03-27 17:17:26
Documents
6

Document Format Files

Seq Description Document Type Size
1 e663457_f6pos-nucana.htm F-6 POS 58556
2 e663457_ex99-ai.htm EX-99.(A)(I) 212429
3 e663457_ex99-aii.htm EX-99.(A)(II) 449265
4 e663457_ex99-bi.htm EX-99.(B)(I) 40013
5 e663457_ex99-bii.htm EX-99.(B)(II) 116196
6 GRAPHIC image1.jpg GRAPHIC 3044
  Complete submission text file 0001193805-24-000454.txt   882410
Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

IRS No.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6 POS
(CF Office: International Corp Fin)

Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Subject) CIK: 0001709626 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-6 POS | Act: 33 | File No.: 333-220392 | Film No.: 24791951
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)